Kyri K. Van Hoose is SVP, CFO of Dermata Therapeutics, Inc.. Currently has a direct ownership of 130,423 shares of DRMA, which is worth approximately $400,398. The most recent transaction as insider was on Dec 23, 2025, when has been sold 122,549 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130K
65.64% 3M change
n/a 12M change
Total Value Held $400,398

Kyri K. Van Hoose Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2025
BUY
Grant, award, or other acquisition
-
122,549 Added 48.44%
130,423 Common Stock
Jan 21 2025
BUY
Grant, award, or other acquisition
-
78,741 Added 50.0%
78,741 Common Stock
KKV

Kyri K. Van Hoose

SVP, CFO
San Diego, CA

Track Institutional and Insider Activities on DRMA

Follow Dermata Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRMA shares.

Notify only if

Insider Trading

Get notified when an Dermata Therapeutics, Inc. insider buys or sells DRMA shares.

Notify only if

News

Receive news related to Dermata Therapeutics, Inc.

Track Activities on DRMA